STAT6 and neoplasm: Indeed, myeloid-specific deletion of cholesterol efflux genes ABCA1 and ABCG1 or inhibition of IL-4R signaling, STAT6, or PI3K has been found to significantly impair tumor progression in an ovarian cancer model [309].